Schnell Bio Pharmaceuticals Inc. is an enterprise in South Korea, with the main office in Seoul. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on December 03, 1960. The total number of employees is currently 425 (2023). In Q3C2025, the company reported a net sales revenue increase of 16.62%. Its’ total assets recorded a negative growth of 4.41%. The net profit margin of Schnell Bio Pharmaceuticals Inc. decreased by 155.15% in 2025.
Headquarters
6301 Ogeum-Ro 19 Gil, Songpa-Gu
Seoul; Seoul;
Postal Code: 138-050
Contact Details: Purchase the Schnell Bio Pharmaceuticals Inc. report to view the information.
Website: http://www.schnell.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service